| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | E García-Vázquez | |
| J M Cabrera-Maqueda | |||
| A E Baidez Guerrero | |||
| E García Molina | |||
| G Valero López | |||
| J Díaz Pérez | |||
| L Fuentes Rumí | |||
| P2860 | cites work | Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding | Q24657908 |
| Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines | Q28249905 | ||
| Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis | Q28256584 | ||
| Imipenem/cilastatin treatment of bacterial meningitis in children | Q28328448 | ||
| 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis | Q30274757 | ||
| Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone | Q30449509 | ||
| Blood brain barrier: development of a structure which supports the functional heterogeneity of the central nervous system | Q30917748 | ||
| Neuron-glial interactions in blood-brain barrier formation. | Q33670796 | ||
| Penetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS. | Q33702049 | ||
| P-Glycoprotein, a gatekeeper in the blood-brain barrier | Q33904245 | ||
| Fine structural localization of a blood-brain barrier to exogenous peroxidase | Q34054533 | ||
| Methods for Quantifying the transport of drugs across brain barrier systems | Q34056795 | ||
| Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability | Q34057451 | ||
| The astrocyte-mediated coupling between synaptic activity and energy metabolism operates through volume transmission. | Q34093906 | ||
| Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections | Q34142328 | ||
| Clinical role of protein binding of quinolones | Q34774058 | ||
| High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins | Q35122014 | ||
| Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains | Q35635671 | ||
| Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis | Q35646489 | ||
| Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy | Q37080236 | ||
| Penetration of colistin into cerebrospinal fluid | Q37409872 | ||
| Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress | Q37622484 | ||
| Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II). | Q38657865 | ||
| Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones | Q38777085 | ||
| The burden and epidemiology of community-acquired central nervous system infections: a multinational study. | Q38843270 | ||
| Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents | Q39189773 | ||
| Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits | Q39779290 | ||
| Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report. | Q40069296 | ||
| ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. | Q40721549 | ||
| Aminoglycoside Therapy of Gram-Negative Bacillary Meningitis | Q41870546 | ||
| Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections | Q42782035 | ||
| Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro | Q43298284 | ||
| Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis | Q43614732 | ||
| Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. | Q43961916 | ||
| Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus | Q43964692 | ||
| Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges | Q44011977 | ||
| Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. | Q44824183 | ||
| Clinical experience with linezolid for the treatment of neurosurgical infections | Q44989907 | ||
| Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid | Q46179208 | ||
| Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state | Q46226363 | ||
| Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin | Q46476420 | ||
| Clinical experience with linezolid for the treatment of central nervous system infections | Q46548640 | ||
| Levels of vancomycin in the cerebral interstitial fluid after severe head injury. | Q46908278 | ||
| Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs | Q47176233 | ||
| Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat | Q48163697 | ||
| Penetration of the blood brain barrier by metronidazole and tinidazole | Q48294445 | ||
| Ceftriaxone pharmacokinetics in the central nervous system | Q48382505 | ||
| Junctions in the meninges and marginal glia | Q48430167 | ||
| Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections | Q48449660 | ||
| Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. | Q48600344 | ||
| Electron microscopic study of the blood-brain and blood-cerebrospinal fluid barriers with microperoxidase. | Q48857407 | ||
| [Brain abscess. The experience of 30 years]. | Q51118400 | ||
| The Blood-Brain Barrier | Q57318251 | ||
| Poor penetration of teicoplanin into cerebrospinal fluid in patients with bacterial meningitis | Q70036308 | ||
| Protein filtration and secretion at human body fluid barriers | Q70649076 | ||
| Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole | Q70986869 | ||
| Influence of lipophilicity on the diffusion of cephalosporins into the cerebrospinal fluid | Q71605197 | ||
| Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis | Q72091997 | ||
| Netilmicin cerebrospinal fluid concentrations after an intravenous infusion of 400 mg in patients without meningeal inflammation | Q72331689 | ||
| Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis | Q72918029 | ||
| Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose | Q79165985 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 1 | |
| P407 | language of work or name | Spanish | Q1321 |
| P921 | main subject | antibiotic | Q12187 |
| P304 | page(s) | 1-12 | |
| P577 | publication date | 2018-01-31 | |
| 2018-02-01 | |||
| P1433 | published in | Revista Española de Quimioterapia | Q20020560 |
| P1476 | title | Antibiotic diffusion to central nervous system | |
| P478 | volume | 31 |
Search more.